Peter M. Ferguson

3.8k total citations
68 papers, 1.5k citations indexed

About

Peter M. Ferguson is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Peter M. Ferguson has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 22 papers in Molecular Biology and 21 papers in Immunology. Recurrent topics in Peter M. Ferguson's work include Cutaneous Melanoma Detection and Management (31 papers), CAR-T cell therapy research (17 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Peter M. Ferguson is often cited by papers focused on Cutaneous Melanoma Detection and Management (31 papers), CAR-T cell therapy research (17 papers) and Cancer Immunotherapy and Biomarkers (17 papers). Peter M. Ferguson collaborates with scholars based in Australia, New Zealand and United States. Peter M. Ferguson's co-authors include Richard A. Scolyer, Ian F. Hermans, Roy Rabbie, David J. Adams, Christian Molina‐Aguilar, Carla Daniela Robles‐Espinoza, Richard D. Tilley, Soshan Cheong, Andrew J. Colebatch and Robert V. Rawson and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Peter M. Ferguson

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter M. Ferguson Australia	21	666	477	473	187	172	68	1.5k
Martina Rudelius Germany	24	594 0.9×	595 1.2×	236 0.5×	264 1.4×	225 1.3×	43	1.8k
Guido Piontek Germany	26	492 0.7×	684 1.4×	311 0.7×	363 1.9×	203 1.2×	58	2.0k
Haidong Tang China	13	930 1.4×	387 0.8×	972 2.1×	584 3.1×	258 1.5×	25	1.9k
Aaron T. Mayer United States	20	901 1.4×	420 0.9×	724 1.5×	476 2.5×	149 0.9×	45	1.8k
Zhiyang Zhou China	22	469 0.7×	308 0.6×	103 0.2×	230 1.2×	193 1.1×	80	1.3k
Wei‐Wei Deng China	22	829 1.2×	708 1.5×	849 1.8×	570 3.0×	189 1.1×	51	2.1k
Arutselvan Natarajan United States	28	820 1.2×	677 1.4×	469 1.0×	746 4.0×	294 1.7×	80	2.5k
Susanne Kossatz Germany	24	760 1.1×	617 1.3×	104 0.2×	475 2.5×	254 1.5×	63	1.8k
Franz Buchegger Switzerland	29	618 0.9×	894 1.9×	230 0.5×	331 1.8×	632 3.7×	85	3.1k

Countries citing papers authored by Peter M. Ferguson

Since Specialization

Citations

This map shows the geographic impact of Peter M. Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Ferguson more than expected).

Fields of papers citing papers by Peter M. Ferguson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Ferguson. The network helps show where Peter M. Ferguson may publish in the future.

Co-authorship network of co-authors of Peter M. Ferguson

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Ferguson. A scholar is included among the top collaborators of Peter M. Ferguson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Ferguson. Peter M. Ferguson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chan, Siew F, Peter M. Ferguson, & Linda Chan. (2025). Clinical Letter: Rapidly Progressive TEN Secondary to Nivolumab and Relatlimab in a Patient With Metastatic Gastric Mucosal Melanoma. Australasian Journal of Dermatology. 66(8). e582–e583.

Potter, Alison J., Peter M. Ferguson, Serigne Lo, et al.. (2024). The Prognostic Significance of Tumoral Melanosis. Journal of Cutaneous Pathology. 53(1). 60–70.

Ferguson, Peter M., Serigne Lo, Helena Collgros, et al.. (2024). In vivo reflectance confocal microscopy role for early to advanced lentigo maligna melanoma spectrum: A systematic review and pooled analysis. Journal of the European Academy of Dermatology and Venereology. 39(3). 555–565. 1 indexed citations

Attrill, Grace H., Tuba N. Gide, Peter M. Ferguson, et al.. (2024). Stroma-infiltrating T cell spatiotypes define immunotherapy outcomes in adolescent and young adult patients with melanoma. Nature Communications. 15(1). 3014–3014. 4 indexed citations

Chan, Siew F, et al.. (2024). Predictors of malignancy in melanocytic lesions presenting as new lesions compared to baseline total body photography: A case–control study. Journal of the European Academy of Dermatology and Venereology. 39(3). 594–603. 1 indexed citations

Nickel, Brooke, David E. Elder, Peter M. Ferguson, et al.. (2024). Impact of alternative diagnostic labels for melanoma in situ on management choices and psychological outcomes: protocol for an online randomised study. BMJ Open. 14(12). e089558–e089558. 2 indexed citations

Pereira, Amanda, et al.. (2022). Dermoscopic features and screening strategies for the detection of small‐diameter melanomas. Clinical and Experimental Dermatology. 47(5). 932–941. 12 indexed citations

Wilmott, James S., Hussein A. Tawbi, Johnathan A. Engh, et al.. (2022). Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases. Clinical Cancer Research. 29(3). 521–531. 9 indexed citations

Scolyer, Richard A., H. Peter Soyer, Peter M. Ferguson, et al.. (2021). Estimating the potential impact of interventions to reduce over‐calling and under‐calling of melanoma. Journal of the European Academy of Dermatology and Venereology. 35(7). 1519–1527. 4 indexed citations

10.

Pereira, Amanda, Pascale Guitera, Peter M. Ferguson, Sydney Ch’ng, & Sérgio Henrique Hirata. (2021). Complex melanoma of the scalp: Diagnosis and management aided by confocal microscopy. Australasian Journal of Dermatology. 63(1). 105–109.

11.

Leslie, Scott, et al.. (2021). Protocol for a Pilot Study of the NODE Trial, a Prospective Multicentre Randomised Trial of Extended Pelvic Lymph Node Dissection for High-Risk Prostate Cancer. SHILAP Revista de lepidopterología. 2(6). 347–353. 1 indexed citations

12.

Ferguson, Peter M., et al.. (2020). Is more dose and skin reaction required when treating early lentigo maligna definitively with radiotherapy? A case series. 7(5). 142–145. 5 indexed citations

13.

Rabbie, Roy, Peter M. Ferguson, Kim Wong, et al.. (2020). The mutational landscape of melanoma brain metastases presenting as the first visceral site of recurrence. British Journal of Cancer. 124(1). 156–160. 28 indexed citations

14.

Edwards, Jarem, Peter M. Ferguson, Serigne Lo, et al.. (2020). Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas. Cancer Immunology Research. 8(11). 1346–1353. 14 indexed citations

15.

Scolyer, Richard A., Robert V. Rawson, Jeffrey E. Gershenwald, Peter M. Ferguson, & Víctor G. Prieto. (2019). Melanoma pathology reporting and staging. Modern Pathology. 33(Suppl 1). 15–24. 70 indexed citations

16.

Hong, Angela, Peter M. Ferguson, D. Brian Jones, et al.. (2019). Significant association of PD-L1 expression with human papillomavirus positivity and its prognostic impact in oropharyngeal cancer. Oral Oncology. 92. 33–39. 51 indexed citations

17.

Gide, Tuba N., Alexander M. Menzies, Peter M. Ferguson, et al.. (2018). Inter‐ and intrapatient heterogeneity of indoleamine 2,3‐dioxygenase expression in primary and metastatic melanoma cells and the tumour microenvironment. Histopathology. 74(6). 817–828. 14 indexed citations

18.

Field, Cameron S., et al.. (2017). Blocking CTLA-4 while priming with a whole cell vaccine reshapes the oligoclonal T cell infiltrate and eradicates tumors in an orthotopic glioma model. OncoImmunology. 7(1). e1376154–e1376154. 21 indexed citations

19.

Bouchery, Tiffany, Ryan Kyle, Mali Camberis, et al.. (2015). ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookworms. Nature Communications. 6(1). 6970–6970. 128 indexed citations

20.

Weinkove, Robert, et al.. (2012). Fever and pancytopenia in a patient with Crohn's disease. Gut. 62(9). 1327–1327. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact